Search for: "v. ALLEGRA" Results 1 - 20 of 38
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jul 2023, 1:40 pm
Here are some v Oral Allergy Syndrome-related questions that you should ask your healthcare provider: ● What foods can I eat? [read post]
23 Feb 2016, 1:53 am
 * English Patent Court speeds up, reminds Mr Justice Carr in Celltrion v BiogenCelltrion Inc. v Biogen Idec Inc., F. [read post]
8 Jan 2016, 9:30 pm by Dan Ernst
  Over at Concurring Opinions, Tuan Samahon, Villanova Law, draws upon Judge Oliver Gasch’s in addressing the likelihood that then-Judge Scalia wrote the per curiam for a three-judge district court that Chief Justice Burger drew upon holding the Gramm-Rudman-Hollings Act unconstitutional in Bowsher v. [read post]
7 Jan 2015, 7:04 pm by Michael Froomkin
Watkins/Proctor & Gamble Professor of Law, The Ohio State University Moritz College of Law Nicole Porter, The Sentencing Project Panel III: The Criminalization of Immigration Law Since the Supreme Court’s landmark opinion in INS v. [read post]
22 Dec 2014, 7:11 am
Allegra Homes , Small Claims Court Deputy Justice Paul Martial said it was “abundantly clear” he does not have jurisdiction over the non-payment claim before him. [read post]
10 Apr 2012, 5:26 pm
Otro Accidente En Un Barco de Costa Posteriormente, el Costa Allegra, un buque gemelo del Costa Concordia, sufrió un incendio de considerable magnitud el 27 de febrero. [read post]
4 Apr 2012, 9:21 am by James Campise
In Deiulemar Compagnia di Navigazione SpA v M/V Allegra, the court allowed depositions, as well as access to documentary and physical evidence in such a circumstance. [read post]
13 Jul 2011, 3:04 am by Marie Louise
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog)   Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re Cyclobenzaprine… [read post]
17 Nov 2010, 1:48 am by Kelly
PhotoCure (FDA Law Blog) US: Clinical trial requirements are top issue at FDA hearings on biosimilars (Patent Docs) Products Allegra (Fenofexadine, Psuedoephedrine) – US: Impax Laboratories receives final FDA approval for generic Allegra-D 60mg/120mg tablets (SmartBrief) Allegra (Fexofenadine) – US: Sanofi-Aventis, Aventisub, Carderm file patent infringement complaint against Aurolife, Aurobindo following Para IV certification (Patent Docs) Boniva (Ibandronate)… [read post]
27 Oct 2010, 3:38 am by Kelly
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows much work… [read post]
23 Jun 2010, 10:28 pm
Reddy's over generic Allegra (Patent Docs) Combigan (Brimonidine) – US: Patent infringement complaint following a Para IV certification: Allergan, Inc. v. [read post]
10 Jun 2010, 3:58 am
Kappos (Patent Docs)   Products Allegra (Fexofenadine) - US: Patent infringement complaint following a Paragraph IV certification: Sanofi-Aventis U.S. [read post]
1 Apr 2010, 3:04 am
(IP tango) Zyprexa (Olanzapine) - Netherlands: District Court of The Hague finds Olanzapine patent and SPC invalid: Ratiopharm v. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech)   Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]